Cargando…
Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic, responsible for millions of deaths globally. Even with effective vaccines, SARS-CoV-2 will likely maintain a hold in the human population through gaps in efficacy, percent vaccinated, and arising new...
Autores principales: | van de Leemput, Joyce, Han, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384068/ https://www.ncbi.nlm.nih.gov/pubmed/34124934 http://dx.doi.org/10.1128/MCB.00185-21 |
Ejemplares similares
-
Updated Approaches against SARS-CoV-2
por: Li, Haiou, et al.
Publicado: (2020) -
Drug Discovery Strategies for SARS-CoV-2
por: Shyr, Zeenat A., et al.
Publicado: (2020) -
Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021) -
Dysregulated liver function in SARS-CoV-2 infection: Current understanding and perspectives
por: Huang, Yi-Ke, et al.
Publicado: (2021) -
Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2
por: van de Leemput, Joyce, et al.
Publicado: (2021)